Alpine to buy Riverside clinical and standardized testing portfolio for $140 mln

Alpine Investors has agreed to acquire the Riverside clinical and standardized testing portfolio of Houghton Mifflin Harcourt for $140 million. Lazard Middle Market provided financial advice to HMH on the deal while WilmerHale acted as HMH’s legal counsel.

DealsNorth AmericaUSBriefs